CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents ($51,253 and $49,227 restricted at December 31, 2019 and December 31, 2020, respectively)	$ 1,144,450	$ 115,752
Accounts receivable, net	743,502	680,569
Short-term investments ($82,772 and $88,867 restricted at December 31, 2019 and December 31, 2020, respectively)	140,847	98,797
Pharmaceutical inventory	43,334	44,962
Other current assets ($36,215 and $43,547 restricted at December 31, 2019 and December 31, 2020, respectively)	84,264	69,687
Current portion of assets held for sale		663,276
Total Current Assets	2,156,397	1,673,043
Property and equipment, net	136,739	131,712
Long-term investments ($2,307 and $1,026 restricted at December 31, 2019 and December 31, 2020, respectively)	2,612	2,864
Deferred income taxes	1,842	1,840
Other long-term assets	108,797	58,905
Goodwill	873,779	806,421
Other intangible assets, net	79,689	81,675
Assets held for sale, less current portion		335,713
Total Assets	3,359,855	3,092,173
Current Liabilities:
Accounts payable	137,380	83,790
Accrued liabilities	354,906	191,854
Medical claims payable	111,851	128,114
Other medical liabilities	126,921	92,915
Current debt, finance lease and deferred financing obligations	6,521	3,491
Current portion of liabilities held for sale		409,983
Total Current Liabilities	737,579	910,147
Long-term debt, finance lease and deferred financing obligations	631,855	679,125
Deferred income taxes	7,102	1,971
Tax contingencies	11,002	9,453
Deferred credits and other long-term liabilities	69,283	56,393
Liabilities held for sale, less current portion		37,301
Total Liabilities	1,456,821	1,694,390
Redeemable non-controlling interest	33,062
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized - 10,000 shares at December 31, 2019 and December 31, 2020-Issued and outstanding-none
Common stock, par value $.01 per share: Authorized - 100,000 shares at December 31, 2019 and December 31, 2020-Issued and outstanding-54,285 and 24,623 shares at December 31, 2019, respectively, and 55,549 and 25,887 shares at December 31, 2020, respectively	555	543
Other Stockholders' Equity:
Additional paid-in capital	1,477,219	1,386,616
Retained earnings	1,857,130	1,475,207
Accumulated other comprehensive income (loss)	(205)	144
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2019 and December 31, 2020, respectively	(1,464,727)	(1,464,727)
Total Stockholders' Equity	1,869,972	1,397,783
Total Liabilities and Stockholders' Equity	$ 3,359,855	$ 3,092,173